MX354598B - Uso de neuregulina para tratar lesion de nervio periferico. - Google Patents

Uso de neuregulina para tratar lesion de nervio periferico.

Info

Publication number
MX354598B
MX354598B MX2014011838A MX2014011838A MX354598B MX 354598 B MX354598 B MX 354598B MX 2014011838 A MX2014011838 A MX 2014011838A MX 2014011838 A MX2014011838 A MX 2014011838A MX 354598 B MX354598 B MX 354598B
Authority
MX
Mexico
Prior art keywords
peripheral nerve
nerve injury
neuregulin
treat peripheral
treat
Prior art date
Application number
MX2014011838A
Other languages
English (en)
Other versions
MX2014011838A (es
Inventor
Anthony O Caggiano
Anindita Ganguly
Jennifer Iaci
Anthony J Bella
Thomas Parry
Raymond Warren Colburn
Original Assignee
Acorda Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acorda Therapeutics Inc filed Critical Acorda Therapeutics Inc
Publication of MX2014011838A publication Critical patent/MX2014011838A/es
Publication of MX354598B publication Critical patent/MX354598B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1883—Neuregulins, e.g.. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición que comprende una cantidad eficaz de una neuregulina para usarse en la disminución de dolor neuropático en un sujeto en riesgo de sufrir una lesión de nervio periférico debido a un procedimiento quirúrgico.
MX2014011838A 2012-03-30 2013-03-29 Uso de neuregulina para tratar lesion de nervio periferico. MX354598B (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201261618381P 2012-03-30 2012-03-30
US201261674060P 2012-07-20 2012-07-20
US201261693589P 2012-08-27 2012-08-27
US201261693585P 2012-08-27 2012-08-27
US201361785419P 2013-03-14 2013-03-14
PCT/US2013/034634 WO2013149163A1 (en) 2012-03-30 2013-03-29 Use of neuregulin to treat peripheral nerve injury

Publications (2)

Publication Number Publication Date
MX2014011838A MX2014011838A (es) 2015-03-09
MX354598B true MX354598B (es) 2018-03-12

Family

ID=48128617

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014011838A MX354598B (es) 2012-03-30 2013-03-29 Uso de neuregulina para tratar lesion de nervio periferico.

Country Status (16)

Country Link
US (3) US20150094263A1 (es)
EP (3) EP2830645B1 (es)
JP (4) JP6420233B2 (es)
CN (2) CN106511971A (es)
AU (4) AU2013237896B2 (es)
BR (1) BR112014024308B1 (es)
CA (1) CA2869070A1 (es)
DK (2) DK3278811T3 (es)
ES (2) ES2647917T3 (es)
HK (2) HK1206632A1 (es)
IL (3) IL288785B2 (es)
MX (1) MX354598B (es)
NZ (1) NZ700546A (es)
PL (2) PL2830645T3 (es)
PT (2) PT2830645T (es)
WO (1) WO2013149163A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2320933T3 (en) 2008-07-17 2018-04-16 Acorda Therapeutics Inc THERAPEUTIC DOSAGE OF A NEUREGULIN OR A SUBSEQUENT THEREOF FOR TREATMENT OR PROPHYLAXY OF HEART FAILURE
EP3235504B1 (en) 2009-10-14 2019-09-18 Acorda Therapeutics, Inc. Use of a neuregulin to treat peripheral nerve injury
ITUB20155471A1 (it) * 2015-11-11 2017-05-11 Univ Degli Studi Di Torino Coniugato della neuregulina 1 per il trattamento delle lesioni dei nervi periferici
EP4338672A3 (en) * 2015-12-04 2024-07-17 University Of Iowa Research Foundation System for screening delirium patients for the presence of encephalopathy
CN111655336A (zh) 2017-11-17 2020-09-11 纽约州立大学研究基金会 使用x射线微束辐射治疗受损周围神经的方法
CN110946991A (zh) * 2018-09-27 2020-04-03 广州中医药大学(广州中医药研究院) 神经调节蛋白1的应用
EP4007527A4 (en) * 2019-08-01 2023-06-28 Mark Evans Methods and apparatus for reducing the risk, and identifying the existence, of neurological injury to a human fetus during and before labor
CN116116737B (zh) * 2023-04-14 2023-06-30 新华手术器械有限公司 止血钳毛坯自动上料装置及使用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US888A (en) 1838-08-20 perkins
US7037A (en) 1850-01-22 Grid-ikon slide-valve
US5530109A (en) 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US5716930A (en) 1991-04-10 1998-02-10 Ludwig Institute For Cancer Research Glial growth factors
US7037888B1 (en) 1992-04-03 2006-05-02 Acorda Therapeutics, Inc. Methods for treating muscle diseases and disorders
US6087323A (en) * 1992-04-03 2000-07-11 Cambridge Neuroscience, Inc. Use of neuregulins as modulators of cellular communication
EP1028735A4 (en) * 1997-10-14 2003-08-06 Cenes Pharmaceuticals Inc THERAPEUTIC METHOD COMPRISING THE USE OF NEUREGULIN
US6890751B2 (en) * 2000-05-23 2005-05-10 Acorda Therapeutics, Inc. NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
WO2009046453A2 (en) * 2007-10-05 2009-04-09 New England Medical Center (Nemc) Use of neuregulin-1 in reducing brain damage
CA2717193C (en) * 2008-02-29 2022-08-16 Acorda Therapeutics, Inc. Method for achieving desired glial growth factor 2 plasma levels
DK2320933T3 (en) * 2008-07-17 2018-04-16 Acorda Therapeutics Inc THERAPEUTIC DOSAGE OF A NEUREGULIN OR A SUBSEQUENT THEREOF FOR TREATMENT OR PROPHYLAXY OF HEART FAILURE
US20120053134A1 (en) * 2009-05-07 2012-03-01 Jae-Hoon Jung Pharmaceutical composition for preventing or treating neuronal damage and neurological diseases
EP3235504B1 (en) * 2009-10-14 2019-09-18 Acorda Therapeutics, Inc. Use of a neuregulin to treat peripheral nerve injury
CA2845198A1 (en) * 2010-08-13 2012-02-16 Georgetown University Ggf2 and methods of use

Also Published As

Publication number Publication date
IL288785B2 (en) 2023-03-01
AU2020260539A1 (en) 2020-11-26
DK3278811T3 (da) 2021-03-01
EP2830645A1 (en) 2015-02-04
IL273186A (en) 2020-04-30
AU2019202401A1 (en) 2019-05-02
JP6420233B2 (ja) 2018-11-07
BR112014024308A2 (pt) 2017-08-08
IL234882B (en) 2020-03-31
US20160346353A1 (en) 2016-12-01
DK2830645T3 (da) 2017-11-20
PL3278811T3 (pl) 2021-08-02
PT3278811T (pt) 2021-03-03
JP7108724B2 (ja) 2022-07-28
AU2013237896B2 (en) 2017-11-02
AU2018200592A1 (en) 2018-02-15
PT2830645T (pt) 2017-11-28
IL234882A0 (en) 2014-12-31
PL2830645T3 (pl) 2018-01-31
JP2021059605A (ja) 2021-04-15
BR112014024308B1 (pt) 2021-11-30
BR112014024308A8 (pt) 2018-01-23
EP3842059A1 (en) 2021-06-30
CN106511971A (zh) 2017-03-22
NZ700546A (en) 2017-05-26
IL288785B (en) 2022-11-01
CN104321072A (zh) 2015-01-28
EP3278811A1 (en) 2018-02-07
AU2019202401B2 (en) 2020-10-15
EP2830645B1 (en) 2017-08-30
EP3278811B1 (en) 2020-12-02
IL273186B (en) 2022-01-01
ES2647917T3 (es) 2017-12-27
CA2869070A1 (en) 2013-10-03
AU2013237896A1 (en) 2014-10-16
JP2015514096A (ja) 2015-05-18
JP2019131582A (ja) 2019-08-08
US20150094263A1 (en) 2015-04-02
MX2014011838A (es) 2015-03-09
HK1206632A1 (en) 2016-01-15
ES2857810T3 (es) 2021-09-29
IL288785A (en) 2022-02-01
WO2013149163A1 (en) 2013-10-03
HK1249038A1 (zh) 2018-10-26
US20230117985A1 (en) 2023-04-20
JP2017149746A (ja) 2017-08-31

Similar Documents

Publication Publication Date Title
MX2014011838A (es) Uso de neuregulina para tratar lesion de nervio periferico.
MX359327B (es) Composiciones y sus usos para tratar y prevenir la enfermedad de huntington.
IN2015DN00438A (es)
MX356525B (es) Vectores de virus asociados con adeno (aav) para uso en terapia de genes de coroideremia.
PH12015500525A1 (en) Formulations of enzalutamide
WO2013177187A3 (en) Synergistic tumor treatment with extended-pk il-2 and therapeutic agents
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
IN2014DN09782A (es)
JO3343B1 (ar) أحماض 5- أمينوتتراهيدروكوينولين-2- كربوكسيليك جديدة واستخدامها
SG10201809290SA (en) Compositions and Methods to Treating Hemoglobinopathies
NZ710444A (en) Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
PH12015501983A1 (en) Peptides and compositions for treatment of joint damage
IN2014DN06792A (es)
MX2014008705A (es) Compuestos tricíclicos de sulfona y métodos para elaborarlos y utilizarlos.
MX356755B (es) Compuestos de tipo fumagilol y metodos para su elaboración y uso.
TN2012000610A1 (en) Heterocyclic compounds, their preparation and their therapeutic application
TN2015000255A1 (fr) Chitine ou ses derives pour la prevention et/ou le traitement de parasitoses
MX2017006019A (es) Apilimod para uso en el tratamiento de melanoma.
MX348040B (es) Antagonistas de hedgehog que tienen residuos que se unen al zinc.
MX2015005732A (es) Compuestos tricíclicos y métodos para hacer y utilizar los mismos.
MX2020009966A (es) Formas de dosificacion y usos terapeuticos de la l-4-cloro quinurenina.
MX364528B (es) Witanólidos útiles para el tratamiento de enfermedades neurodegenerativas.
MX2015005733A (es) Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
MX2015000804A (es) Composiciones y metodos para tratar el sarcoma de ewing y otros trastornos relacionados con ews-fli1.
MX362111B (es) Un metodo para mejorar la funcion hepatica.

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration